Engineered Oncolytic Adenoviruses: An Emerging Approach for Cancer Therapy

Tan, Ee Wern * and Noraini, Abd-Aziz * and Poh, Chit Laa * and Tan, Kuan Onn * (2022) Engineered Oncolytic Adenoviruses: An Emerging Approach for Cancer Therapy. Pathogens and Global Health, 11 (10). ISSN 2047-7724

[img]
Preview
Text
Tan Ee Wern_Engineered Oncolytic Adenoviruses.pdf - Published Version
Available under License Creative Commons Attribution.

Download (958kB) | Preview
Official URL: https://doi.org/10.3390/pathogens11101146

Abstract

Cancer is among the major leading causes of mortality globally, and chemotherapy is currently one of the most effective cancer therapies. Unfortunately, chemotherapy is invariably accompanied by dose-dependent cytotoxic side effects. Recently, genetically engineered adenoviruses emerged as an alternative gene therapy approach targeting cancers. This review focuses on the characteristics of genetically modified adenovirus and oncology clinical studies using adenovirus-mediated gene therapy strategies. In addition, modulation of the tumor biology and the tumor microenvironment as well as the immunological responses associated with adenovirus-mediate cancer therapy are discussed.

Item Type: Article
Uncontrolled Keywords: oncolytic adenovirus; immune system; tumor microenvironment (TME); cancer therapy
Subjects: Q Science > QR Microbiology
R Medicine > RC Internal medicine
Divisions: Sunway University > School of Medical and Life Sciences [formerly School of Healthcare and Medical Sciences until 2020] > Dept. Biological Sciences
Sunway University > School of Medical and Life Sciences [formerly School of Healthcare and Medical Sciences until 2020] > Sunway Microbiome Centre [formerly Centre for Virus and Vaccine Research until 2023]
Depositing User: Ms Yong Yee Chan
Related URLs:
Date Deposited: 12 Aug 2024 08:37
Last Modified: 12 Aug 2024 08:37
URI: http://eprints.sunway.edu.my/id/eprint/3077

Actions (login required)

View Item View Item